[Pharmacological and clinical profile of silodosin (URIEF Cap. 2 mg, 4 mg)].
Kobayashi
Mamoru
M
mamoru_kobayashi@pharm.kissei.co.jp
Shimizu
Tomoji
T
D018674:Adrenergic Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D051381:Rats; D014555:Urination Disorders / Q000188:drug therapy*
D018674:Adrenergic Antagonists; D007211:Indoles; C095285:silodosin